Search results
Found 2794 matches for
Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
OVG Alumni
Browse the OVG Alumni, including those who have undertaken a PhD/DPhil, MSc or MD (a graduate degree in the UK for medical graduates) at OVG since 2001, with date of graduation and where available information on their current or most recent/notable role.
Research
The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
Study & Train @ OVG
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.